Soc. Generale Discount Zert NKE 2.../ DE000SV9PCX9 /
31/05/2024 21:36:43 | Diferencia-0.050 | Bid21:59:40 | Ask21:59:40 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
54.370EUR | -0.09% | 54.340 Volumen de oferta: 1,000 |
54.350 Tamaño/ Volumen/ Formato de Ask: 1,000 |
Nike Inc | - USD | 27/09/2024 | Call |
GlobeNewswire
2:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página